Stem Cells Therapy in General Medicine

Abduzhappar Gaipov; Askhat Myngbay

doi:10.29333/ejgm/83014

Full Text (PDF)

Abduzhappar Gaipov ^* , Askhat Myngbay

More Detail

^* Corresponding Author

Abstract

Editorial

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Editorial

https://doi.org/10.29333/ejgm/83014

ELECTRON J GEN MED, 2018 - Volume 15 Issue 2, Article No: em01

Publication date: 17 Jan 2018

Article Views: 1638

Article Downloads: 2020

Open Access Disclosures References How to cite this article

Disclosure

Declaration of Conflict of Interest: No conflict of interest is declared by author(s).

References

Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19(3):193-204. https://doi.org/10.1634/stemcells.19-3-193.
Hans R. The potential of stem cells: An inventory. Human biotechnology as Social Challenge, England, Ashgate Publishing, Ltd. 2007;28.
Strauer B, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg R, et al. Intrakoronare, humane autologe Stammzelltransplantation zur Myokardregeneration nach Herzinfarkt. DMW-Deutsche Medizinische Wochenschrift. 2001;126(34/35):932-8. https://doi.org/10.1055/s-2001-16579-1.
Rakhimbekova GA, Tuganbekova SK, Askarov MB, Zhusupova AS, Krivoruchko NA, Akshalova GA, et al. Autologous hematopoietic stem cell transplantation in systemic sclerosis. J Clin Med Kaz. 2013;3(29):7-10.
Gaipov A, Taubaldiyeva Z, Askarov M, Turebekov Z, Popova N, Tuganbekova S. Impact of autologous bone marrow-derived stem cells to markers of renal deterioration in type 1 diabetes mellitus with nephropathy. Nephrology Dialysis Transplantation. 2015;30(suppl 3):iii534-iii. https://doi.org/10.1093/ndt/gfv195.10.
Dzholdasbekova A, Fedotovskikh G, Askarov M, Komsabakova B, Baigenzhina A, Kairatova A, et al. Systemic administration of autologous mononuclear precultured bone marrow stem cells in heart failure. J Clin Med Kaz. 2015;3(37):14-8.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. https://doi.org/10.1080/14653240600855905.
Gaipov A, Turebekov Z, Serebrennikova D, Kozina L, Askarov M, Tuganbekova S. Autologous bone marrow-derived stem cells transplantation in type I diabetes mellitus. Nephrology Dialysis Transplantation. 2016;31(suppl 1):i217-i. https://doi.org/10.1093/ndt/gfw169.03.
Tuganbekova S, Gaipov A, Turebekov Z, Saparbayev S, Shaimardanova G, Popova N, et al. Fetal Renal Stem Cell Transplant in Nephrotic and Nonnephrotic Glomerulonephritis with Stage 2-4 Chronic Kidney Disease: Potential Effect on Proteinuria and Glomerular Filtration Rate. Exp Clin Transplant. 2015;13 Suppl 3:156-9.
Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007;109(1):228-34. https://doi.org/10.1182/blood-2006-02-002246.
Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262(5):509-25. https://doi.org/10.1111/j.1365-2796.2007.01844.x.
Keating A. How do mesenchymal stromal cells suppress T cells? Cell stem cell. 2008;2(2):106-8. https://doi.org/10.1016/j.stem.2008.01.007.
Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, et al. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats. Clin Immunol. 2008;127(3):348-58. https://doi.org/10.1016/j.clim.2008.02.003.
Tian Y, Deng YB, Huang YJ, Wang Y. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Immunol Invest. 2008;37(1):29-42. https://doi.org/10.1080/08820130701410223.
Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008;15(2):109-16. https://doi.org/10.1038/sj.gt.3303067.
Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol. 2007;18(6):846-58. https://doi.org/10.1016/j.semcdb.2007.09.012.
Crovace A, Lacitignola L, De Siena R, Rossi G, Francioso E. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun. 2007;31 Suppl 1:281-3. https://doi.org/10.1007/s11259-007-0047-y.
Beeres SL, Lamb HJ, Roes SD, Holman ER, Kaandorp TA, Fibbe WE, et al. Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia. J Magn Reson Imaging. 2008;27(5):992-7. https://doi.org/10.1002/jmri.21081.
Bartsch T, Brehm M, Zeus T, Strauer BE. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nurs. 2006;21(6):430-2. https://doi.org/10.1097/00005082-200611000-00003.
Schafer R, Wiskirchen J, Guo K, Neumann B, Kehlbach R, Pintaske J, et al. Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. Rofo. 2007;179(10):1009-15. https://doi.org/10.1055/s-2007-963409.
Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986-8001. https://doi.org/10.3390/ijms140917986.
Charif N, Li YY, Targa L, Zhang L, Ye JS, Li YP, et al. Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine. Biomed Mater Eng. 2017;28(s1):S57-S63. https://doi.org/10.3233/BME-171624.
Tuganbekov T, Askarov M, Ashimov N, Saipiyeva D. Stem Cells Therapy of Lower Extremity Ulcers. J Clin Med Kaz. 2013;4(30):14-20.
Kayupov B, Saparbayev S, Ualiyeva S, Kassymova Z, Oralbay A, Zhakupova A, et al. Development of lyophilized drug of human hepatocytes for the liver failure treatment. J Clin Med Kaz. 2013;4(30):70-6.
Tabatabaei FS, Samadi R, Tatari S. Surface characteristics of three commercially available grafts and adhesion of stem cells to these grafts. Bio-medical materials and engineering. 2017;28(6):621-31. https://doi.org/10.3233/BME-171700.
Davies BM, Smith J, Rikabi S, Wartolowska K, Morrey M, French A, et al. A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. J Tissue Eng. 2017;8:2041731417724413. https://doi.org/10.1177/2041731417724413.
Abbasalizadeh S, Pakzad M, Cabral JMS, Baharvand H. Allogeneic cell therapy manufacturing: process development technologies and facility design options. Expert Opin Biol Ther. 2017;17(10):1201-19. https://doi.org/10.1080/14712598.2017.1354982.
Li Pira G, Biagini S, Cicchetti E, Merli P, Brescia LP, Milano GM, et al. Immunoselection techniques in hematopoietic stem cell transplantation. Transfus Apher Sci. 2016;54(3):356-63. https://doi.org/10.1016/j.transci.2016.05.012.
Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31(10):890-6. https://doi.org/10.1016/S0301-472X(03)00110-3.
Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252-60. https://doi.org/10.1038/nbt.2816.

How to cite this article

Vancouver

Gaipov A, Myngbay A. Stem Cells Therapy in General Medicine. ELECTRON J GEN MED. 2018;15(2):em01. https://doi.org/10.29333/ejgm/83014

APA

Gaipov, A., & Myngbay, A. (2018). Stem Cells Therapy in General Medicine. Electronic Journal of General Medicine, 15(2), em01. https://doi.org/10.29333/ejgm/83014

AMA

Gaipov A, Myngbay A. Stem Cells Therapy in General Medicine. ELECTRON J GEN MED. 2018;15(2), em01. https://doi.org/10.29333/ejgm/83014

Chicago

Gaipov, Abduzhappar, and Askhat Myngbay. "Stem Cells Therapy in General Medicine". Electronic Journal of General Medicine 2018 15 no. 2 (2018): em01. https://doi.org/10.29333/ejgm/83014

Harvard

Gaipov, A., and Myngbay, A. (2018). Stem Cells Therapy in General Medicine. Electronic Journal of General Medicine, 15(2), em01. https://doi.org/10.29333/ejgm/83014

MLA

Gaipov, Abduzhappar et al. "Stem Cells Therapy in General Medicine". Electronic Journal of General Medicine, vol. 15, no. 2, 2018, em01. https://doi.org/10.29333/ejgm/83014